
Craneware plc
("Craneware" or the "Company" or the "Group")
Dividend Currency Election
21 March 2025 - Craneware plc (AIM: CRW.L), a leader in healthcare financial performance solutions, today gives further information regarding its interim dividend announced on 11 March 2025.
For those shareholders who have previously registered to receive their dividend in US dollars under the Company's Dividend Currency Election, the dividend will be paid at an exchange rate of $1.30.
For further information, please contact:
Craneware plc | +44 (0)131 550 3100 |
Keith Neilson, CEO | |
Craig Preston, CFO | |
| |
Alma Strategic Communications (Financial PR) | +44 (0)20 3405 0205 |
Caroline Forde, Kinvara Verdon, Sarah Peters | craneware@almastrategic.com |
| |
Peel Hunt (NOMAD and Joint Broker) | +44 (0)20 7418 8900 |
Neil Patel, Benjamin Cryer, Kate Bannatyne | |
| |
Investec Bank PLC (Joint Broker) | +44 (0)20 7597 5970 |
Patrick Robb, Virginia Bull, James Smith | |
|
|
Berenberg (Joint Broker) | +44 (0)20 3207 7800 |
Mark Whitmore, Richard Andrews, Patrick Dolaghan | |
About The Craneware Group
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth.
As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster-that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider.
The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve-today and in the future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.